Blood Pressure During Rate Control in Patients With Tachycardic Atrial Fibrillation at the Emergency Department (BPIRCTPTAF)

Medical University of Vienna

Status: Unknown

Conditions: Atrial Fibrillation

Treatments: Other: Rate control

Study type: Observational

Funder types: Other

Identifiers

NCT04005482

MUVienna 1568/2014

Details and patient eligibility

About

The aim of this study is to analyse blood pressure during rate control therapy in patients with tachycardic atrial fibrillation in a real-world emergency cohort.

Full description

Atrial fibrillation (AF) is the primary clinical problem in 3.3% to 10.0 % emergency department (ED) admissions. Rate control is an integral part of the management of symptomatic tachycardic AF patients.

According to the recent guidelines beta-blockers, digoxin, the calcium channel blockers diltiazem and verapamil, amiodarone or combination therapy should be considered for rate control. Haemodynamic side-effects in particular hypotension may occur. Heart rate and blood pressure behavior in an ED population during rate control therapy in patients with tachycardic atrial fibrillation will be analysed.

Enrollment: 140 estimated patients

Sex: All

Ages: 18 to 120 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age > 18 years
• Atrial fibrillation or atrial flutter and heart rate ≥ 110 bpm
• Indication for rate control
• Informed consent

Exclusion criteria

• Inclusion criteria not met